VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

Clinical trial NCT04842747 · COMPLETED

Trial details

NCT number: NCT04842747
Sponsor: Veru Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV Infection

Start date: 2021-05-18
Primary completion: 2022-07-06
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.